Fibrosis Research
2006
October
Liver Fibrosis in Women with Chronic Hepatitis
C
August
Non-invasive Assessment of Liver Fibrosis in
Patients with Hepatitis C
Hepatic
fibrosis in Hispanics
Is HCV Infection Associated with Liver
Steatosis in Children?
Diabetes Increases Fibrosis in Patients Transplanted
for Hep C
July
Smoking May Worsen Liver Fibrosis in Patients with
Hepatitis C
Hispanics with Chronic Hepatitis C May Develop More
Advanced Fibrosis
Hepatic Steatosis Is Associated with Fibrosis, Nucleoside Analogue Use, and
Hepatitis C Virus Genotype 3 Infection in HIV-Seropositive Patients:
Steatosis was present in 69% of patients
June
Fibrosis progression in initially mild chronic
hepatitis C
From DDW
BMI, Insulin Resistance Contribute to Fibrosis -
(06/12/06)
Thiazolidinediones and hepatic fibrosis: don't wait too long
-
(06/12/06)
Insulin Resistance Influences Liver Inflammation
Abstract 651 – Sustained virological response leads to an improved clinical
outcome in patients with chronic hepatitis C and advanced fibrosis
Abstract S1913 – Serum Hyaluronic Acid (HA), YKL-40, FibroSpect-II (FS-II)
Test and Digital Quantification of Fibrosis (DQF) Correlate With Ishak
Fibrosis Scores in Patients With Chronic Hepatitis C (HCV)
Abstract S1912 – Accuracy of indices utilizing common lab values in
predicting hepatic fibrosis and cirrhosis in hepatitis C patients in a
community setting
Abstract 554 – Diagnostic Liver Biopsy in Patients wWith Advanced Fibrosis
and Cirrhosis
Abstract S1043 – Polymorphisms in TLR7 and 8 affect severity of hepatic
fibrosis and inflammation in individuals infected with the hepatitis C virus
from a single source.
Abstract S1045 – Can we predict advanced fibrosis in daily practice based on
common blood tests?
Abstract S1050 – Liver fibrosis and necroinflammatory activity in chronic
hepatitis C patients with persistently normal aminotransferases
Abstract S1056 – Steatosis associated with more severe fibrosis in in
chronic hepatitis C.
(From Advocate)
The effect of liver fibrosis and cirrhosis on SVR in 4913 patients with
hepatitis C; Results from the Win-R trial
May
From HIV&HEPATITIS
The
Effect of Liver Fibrosis and Cirrhosis on SVR in 4913 Patients with
Hepatitis C: Results from the Win-R Trial
-
5/23/06
Retreatment with Peginterferon Alfa-2a
(Pegasys) Plus Ribavirin of Nonresponders with Cirrhosis/Advanced Fibrosis
to Peginterferon Alfa-2b (PegIntron)
- 5/23/06
Combined Contrast-Enhanced MRI May Be Useful for
Staging Liver Fibrosis in NAFLD
May 15
Mar
Hepatic Iron, Liver Steatosis and HCV Genotypes in
Patients with Chronic Hepatitis C
-
3/14/06
|
